Can quality of life assessments differentiate heterogeneous cancer patients?

ABSTRACT:

Purpose

This research conducted a face validation study of patient responses to the application of an HRQOL assessment research tool in a comprehensive community cancer program setting across a heterogeneous cohort of cancer patients throughout the natural history of diagnosed malignant disease, many of whom would not be considered candidates for clinical research trial participation.

Methods

Cancer registries at two regional cancer treatment centers identified 11072 cancer patients over a period of nine years. The EORTC QLQ-C30 was administered to patients at the time of their initial clinical presentation to these centers. To determine the significance of differences between patient subgroups, two analytic criteria were used. The Mann-Whitney test was used to determine sta

SUBMITTER: McCabe RM 

PROVIDER: S-EPMC4053440 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature